Information for "Efficacy along with basic safety of alirocumab as opposed to ezetimibe in substantial aerobic threat Chinese language sufferers together with hyperlipidemia ODYSSEY Eastern side StudyChinese subpopulation analysis"
From EECH Central
Basic information
Display title | Efficacy along with basic safety of alirocumab as opposed to ezetimibe in substantial aerobic threat Chinese language sufferers together with hyperlipidemia ODYSSEY Eastern side StudyChinese subpopulation analysis |
Default sort key | Efficacy along with basic safety of alirocumab as opposed to ezetimibe in substantial aerobic threat Chinese language sufferers together with hyperlipidemia ODYSSEY Eastern side StudyChinese subpopulation analysis |
Page length (in bytes) | 3,354 |
Page ID | 1290982 |
Page content language | English (en) |
Page content model | wikitext |
Indexing by robots | Allowed |
Number of redirects to this page | 0 |
Page protection
Edit | Allow all users (infinite) |
Move | Allow all users (infinite) |
Edit history
Page creator | Lumbertuba2 (Talk | contribs) |
Date of page creation | 10:14, 22 March 2024 |
Latest editor | Lumbertuba2 (Talk | contribs) |
Date of latest edit | 10:14, 22 March 2024 |
Total number of edits | 1 |
Total number of distinct authors | 1 |
Recent number of edits (within past 90 days) | 1 |
Recent number of distinct authors | 1 |